Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-07

Clinical Trial Update: A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating RBT-1 in healthy volunteers and patients with stage 3/4 chronic kidney disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RBT-1

Snippet

Sponsor: Renibus Therapeutics, Inc. | Conditions: Healthy Volunteers, Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-08-07